1. Effects of Oral Hyaluronic Acid Administration in Dogs Following Tibial Tuberosity Advancement Surgery for Cranial Cruciate Ligament Injury
- Author
-
J. I. Redondo, C. Soler, Juan José Ramos-Plá, Víctor Moratalla, Claudio Iván Serra Aguado, Sergi Segarra, Producción Científica UCH 2021, and UCH. Departamento de Medicina y Cirugía Animal
- Subjects
medicine.medical_specialty ,Hyaluronic acid - Therapeutic use ,Osteoarthritis in dogs ,040301 veterinary sciences ,Veterinary medicine ,canine ,Osteoarthritis ,Osteoartritis en los perros - Tratamiento ,Ácido hialurónico - Uso terapéutico ,Placebo ,Article ,cranial cruciate ligament ,0403 veterinary science ,Cruciate ligament ,Ligamentos - Cirugía ,03 medical and health sciences ,chemistry.chemical_compound ,Tibial tuberosity advancement ,synovial fluid ,Oral administration ,Hyaluronic acid ,hyaluronic acid ,SF600-1100 ,medicine ,Synovial fluid ,paraoxonase-1 ,Ligaments - Surgery ,030304 developmental biology ,Dogs - Surgery ,0303 health sciences ,General Veterinary ,biology ,business.industry ,Haptoglobin ,04 agricultural and veterinary sciences ,medicine.disease ,Surgery ,Perros - Cirugía ,osteoarthritis ,medicine.anatomical_structure ,chemistry ,QL1-991 ,biology.protein ,Animal Science and Zoology ,business ,Zoology - Abstract
Hyaluronic acid (HA) intraarticular injection is used in the management of osteoarthritis in veterinary medicine. However, HA oral administration is less common given the scarce currently available scientific evidence. This study was aimed at evaluating the effects of oral HA administration on synovial fluid concentrations of several selected biomarkers in dogs with cranial cruciate ligament (CCL) injury operated on using the tibial tuberosity advancement (TTA) technique. Fifty-five dogs were included in this prospective, randomized, double-blind, clinical study, they were randomly assigned to receive either a placebo (group A, n = 25) or HA (group B, n = 30) orally for 10 weeks. Synovial fluid samples were obtained before surgery, and at 10 weeks postoperatively to measure concentrations of HA, haptoglobin, nitric oxide, and paraoxonase-1. After 10 weeks, group HA showed a significant increase in HA concentration (p = 0.0016) and a significant decrease in PON-1 concentration (p = 0.011) compared to baseline. In conclusion, post-op oral HA administration in canine patients with CCL injury leads to improvements in osteoarthritis biomarkers, namely higher synovial fluid HA concentrations and reduced synovial fluid paraoxonase-1 concentrations. These findings support the bioavailability of orally-administered HA and its usefulness in improving biomarkers of osteoarthritis.
- Published
- 2021